LOINC Code 85323-4: Response to neoadjuvant therapy Ql (Breast cancer specimen)

What is this code?

LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Response to neoadjuvant therapy. It is commonly used with the system or sample type Breast cancer specimen.

When is it used?

• Used in lab systems, EHRs, and clinical data exchange.
• May identify a test, observation, survey item, or clinical document request rather than a diagnosis.
• Status: ACTIVE
• Order vs observation: Observation

What it does not mean

• The code identifies the observation or test, not the actual result.

Key facts

• Response to neoadjuvant therapy in Breast cancer specimen Qualitative
• Response to neoadjuvant therapy
• The response of the tumor to neoadjuvant treatment, such as chemotherapy or endocrine therapy. The response of invasive breast carcinoma to neoadjuvant therapy is associated with increased disease-free and overall survival.
• Br ca spec; Brst; CA; Ca spec; Finding; Findings; Ordinal; PATHOLOGY; Point in time; QL; Qual; Qualitative; Random; Resp to neoadjvt therapy; Screen; Spec

Where you may see this code

You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges.

Common synonyms

Frequently asked questions